BioLineRx Ltd. (BLRX)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 49.18M |
| Enterprise Value | 17.78M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.33 |
| Price/Book (mrq) | 3.76 |
| Enterprise Value/Revenue | 3.70 |
| Enterprise Value/EBITDA | 0.46 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.92 |
| 52-Week Change 3 | -58.67% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 2.5300 |
| 52 Week Low 3 | 0.5500 |
| 50-Day Moving Average 3 | 0.8210 |
| 200-Day Moving Average 3 | 1.3391 |
Share Statistics
| Avg Vol (3 month) 3 | 414.08k |
| Avg Vol (10 day) 3 | 222.4k |
| Shares Outstanding 5 | 79.94M |
| Implied Shares Outstanding 6 | 75.17M |
| Float 8 | 989.89M |
| % Held by Insiders 1 | 8.54% |
| % Held by Institutions 1 | 1.73% |
| Shares Short (Apr 30, 2024) 4 | 410.59k |
| Short Ratio (Apr 30, 2024) 4 | 1.21 |
| Short % of Float (Apr 30, 2024) 4 | N/A |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.51% |
| Shares Short (prior month Mar 28, 2024) 4 | 591.45k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jul 15, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Jul 15, 2019 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -247.15% |
Management Effectiveness
| Return on Assets (ttm) | -38.30% |
| Return on Equity (ttm) | -189.23% |
Income Statement
| Revenue (ttm) | 4.8M |
| Revenue Per Share (ttm) | 0.08 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -42.17M |
| Net Income Avi to Common (ttm) | -60.61M |
| Diluted EPS (ttm) | -0.9000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 42.99M |
| Total Cash Per Share (mrq) | 0.04 |
| Total Debt (mrq) | 11.59M |
| Total Debt/Equity (mrq) | 87.66% |
| Current Ratio (mrq) | 1.53 |
| Book Value Per Share (mrq) | 0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22.61M |
| Levered Free Cash Flow (ttm) | -9.6M |
© 2024 Yahoo. All rights reserved.